MaxCell BioScience – Trademark Portfolio

Entity Type: 03

MaxCell BioScience has 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Filings span 5 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 16 (Paper Goods). This trademark owner is based in Broomfield, CO.

100 Technology Drive, Suite 325

Broomfield, CO 80021

14 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

MaxCell BioScience's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

16
Paper Goods (4 filings)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

9
Computers & Electronics (3 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does MaxCell BioScience have?

MaxCell BioScience has 14 U.S. trademarks filed with the USPTO.

What trademark classes does MaxCell BioScience file in?

MaxCell BioScience files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 16 (Paper Goods), Class 9 (Computers & Electronics), Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is MaxCell BioScience's trademark registration success rate?

MaxCell BioScience has a 0% trademark registration rate, with 0 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.